CuraSen Therapeutics Appoints Kathleen Sereda Glaub as CEO
Key Highlights Kathleen Sereda Glaub appointed as Chief Executive Officer of CuraSen Therapeutics. Dr. Anthony Ford takes on the role of President and…
Browsing Tag
Patrick Enright
2 posts
BioAge Secures $170M for Obesity Drug Development
Key Highlights $170 million Series D financing led by Sofinnova Investments with participation from top investors and pharma companies.…